Clinical Trial

Effects of Pulmonary Resection on Right Ventricular Function

Completed
View on ClinicalTrials.gov →
Summary
Lung resection is associated with high postoperative morbidity and mortality and leads to a significant long-term decrease in functional capacity, particularly due to cardiorespiratory complications. One of the contributing factors to this functional decline is the postoperative reduction in right ventricular function. Due to the anatomical proximity and interactions, right ventricular function is evaluated by echocardiography following lung resection. The pulmonary artery pressure (PAP)/tricuspid annular plane systolic excursion (TAPSE) ratio is a parameter that provides a more comprehensive assessment of right heart function by evaluating both right ventricular systolic function and pulmonary artery pressure. In this study, investigators aimed to evaluate changes in right heart function by performing preoperative and postoperative echocardiographic assessments in participants undergoing lung resection, focusing on PAP/TAPSE ratios.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-20; most recent amendment 2026-05-22.
Status change: Recruiting → Completed 2026-05-22
Trial Details
NCT Number NCT07042893
Lead Sponsor Çağrı Özdemir
Conditions Pulmonary Resection, Right Ventricular Function, Echocardiography, Cardiothoracic Anesthesia
Enrollment 33 participants
Start Date 2025-04-01
Primary Completion 2026-04-24 (estimated)
Study Completion 2026-05-15 (estimated)
Updated on ClinicalTrials.gov 2026-05-26